These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

295 related articles for article (PubMed ID: 28684305)

  • 41. Gap junctions and hemichannels composed of connexins: potential therapeutic targets for neurodegenerative diseases.
    Takeuchi H; Suzumura A
    Front Cell Neurosci; 2014; 8():189. PubMed ID: 25228858
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Arginase 1+ microglia reduce Aβ plaque deposition during IL-1β-dependent neuroinflammation.
    Cherry JD; Olschowka JA; O'Banion MK
    J Neuroinflammation; 2015 Nov; 12():203. PubMed ID: 26538310
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The role of microglia in the development of neurodegeneration.
    Saitgareeva AR; Bulygin KV; Gareev IF; Beylerli OA; Akhmadeeva LR
    Neurol Sci; 2020 Dec; 41(12):3609-3615. PubMed ID: 32458252
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Design, synthesis and evaluation of a series of non-steroidal anti-inflammatory drug conjugates as novel neuroinflammatory inhibitors.
    Xu Z; Wu J; Zheng J; Ma H; Zhang H; Zhen X; Zheng LT; Zhang X
    Int Immunopharmacol; 2015 Apr; 25(2):528-37. PubMed ID: 25765352
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Alterations in immune cells and mediators in the brain: it's not always neuroinflammation!
    Estes ML; McAllister AK
    Brain Pathol; 2014 Nov; 24(6):623-30. PubMed ID: 25345893
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Identification of glia phenotype modulators based on select glial function regulatory signaling pathways.
    Lee SH; Suk K
    Expert Opin Drug Discov; 2018 Jul; 13(7):627-641. PubMed ID: 29676181
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Drugs to Treat Neuroinflammation in Neurodegenerative Disorders.
    Wang YC; Kung WM; Chung YH; Kumar S
    Curr Med Chem; 2024; 31(14):1818-1829. PubMed ID: 37013428
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Neuroinflammation: no rose by any other name.
    Graeber MB
    Brain Pathol; 2014 Nov; 24(6):620-2. PubMed ID: 25345892
    [No Abstract]   [Full Text] [Related]  

  • 49. Cross-talk between LRRK2 and PKA: implication for Parkinson's disease?
    Greggio E; Bubacco L; Russo I
    Biochem Soc Trans; 2017 Feb; 45(1):261-267. PubMed ID: 28202680
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Neuro-Coagulopathy: Blood Coagulation Factors in Central Nervous System Diseases.
    De Luca C; Virtuoso A; Maggio N; Papa M
    Int J Mol Sci; 2017 Oct; 18(10):. PubMed ID: 29023416
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Neuronal injury in chronic CNS inflammation.
    Zindler E; Zipp F
    Best Pract Res Clin Anaesthesiol; 2010 Dec; 24(4):551-62. PubMed ID: 21619866
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Extracellular TDP-43 aggregates target MAPK/MAK/MRK overlapping kinase (MOK) and trigger caspase-3/IL-18 signaling in microglia.
    Leal-Lasarte MM; Franco JM; Labrador-Garrido A; Pozo D; Roodveldt C
    FASEB J; 2017 Jul; 31(7):2797-2816. PubMed ID: 28336525
    [TBL] [Abstract][Full Text] [Related]  

  • 53. The role of regulatory T cells in nervous system pathologies.
    Duffy SS; Keating BA; Perera CJ; Moalem-Taylor G
    J Neurosci Res; 2018 Jun; 96(6):951-968. PubMed ID: 28488363
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Inflammasome signaling at the heart of central nervous system pathology.
    Chakraborty S; Kaushik DK; Gupta M; Basu A
    J Neurosci Res; 2010 Jun; 88(8):1615-31. PubMed ID: 20127816
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The Emerging Role of Central and Peripheral Immune Systems in Neurodegenerative Diseases.
    Zang X; Chen S; Zhu J; Ma J; Zhai Y
    Front Aging Neurosci; 2022; 14():872134. PubMed ID: 35547626
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Hydrogen Sulfide and Neuroinflammation.
    Kida K; Ichinose F
    Handb Exp Pharmacol; 2015; 230():181-9. PubMed ID: 26162835
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Aging and Neuroinflammatory Disorders: New Biomarkers and Therapeutic Targets.
    Gambino CM; Sasso BL; Bivona G; Agnello L; Ciaccio M
    Curr Pharm Des; 2019; 25(39):4168-4174. PubMed ID: 31721696
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Chitinase Signature in the Plasticity of Neurodegenerative Diseases.
    Russo C; Valle MS; Casabona A; Malaguarnera L
    Int J Mol Sci; 2023 Mar; 24(7):. PubMed ID: 37047273
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Mast cells and neuroinflammation.
    Dong H; Zhang X; Qian Y
    Med Sci Monit Basic Res; 2014 Dec; 20():200-6. PubMed ID: 25529562
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Multiple Sclerosis and Neuroinflammation: The Overview of Current and Prospective Therapies.
    Bjelobaba I; Savic D; Lavrnja I
    Curr Pharm Des; 2017; 23(5):693-730. PubMed ID: 27981909
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.